Last reviewed · How we verify

Bupivacaine with intrathecal morphine

Centre Hospitalier Universitaire Vaudois · FDA-approved active Small molecule

Bupivacaine with intrathecal morphine is a Local anesthetic with intrathecal opioid Small molecule drug developed by Centre Hospitalier Universitaire Vaudois. It is currently FDA-approved for Perioperative analgesia and anesthesia, Spinal anesthesia with enhanced postoperative pain control.

Bupivacaine blocks sodium channels in nerve fibers to provide local anesthesia, while intrathecal morphine binds to opioid receptors in the spinal cord to provide analgesia.

Bupivacaine blocks sodium channels in nerve fibers to provide local anesthesia, while intrathecal morphine binds to opioid receptors in the spinal cord to provide analgesia. Used for Perioperative analgesia and anesthesia, Spinal anesthesia with enhanced postoperative pain control.

At a glance

Generic nameBupivacaine with intrathecal morphine
SponsorCentre Hospitalier Universitaire Vaudois
Drug classLocal anesthetic with intrathecal opioid
TargetVoltage-gated sodium channels (bupivacaine); mu-opioid receptors (morphine)
ModalitySmall molecule
Therapeutic areaAnesthesia and Pain Management
PhaseFDA-approved

Mechanism of action

Bupivacaine is a long-acting local anesthetic that prevents nerve impulse transmission by blocking voltage-gated sodium channels. Morphine, when administered intrathecally (directly into cerebrospinal fluid), acts on mu-opioid receptors in the spinal cord to modulate pain signaling. This combination provides both immediate local anesthetic effect and prolonged opioid-mediated analgesia for perioperative pain management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Bupivacaine with intrathecal morphine

What is Bupivacaine with intrathecal morphine?

Bupivacaine with intrathecal morphine is a Local anesthetic with intrathecal opioid drug developed by Centre Hospitalier Universitaire Vaudois, indicated for Perioperative analgesia and anesthesia, Spinal anesthesia with enhanced postoperative pain control.

How does Bupivacaine with intrathecal morphine work?

Bupivacaine blocks sodium channels in nerve fibers to provide local anesthesia, while intrathecal morphine binds to opioid receptors in the spinal cord to provide analgesia.

What is Bupivacaine with intrathecal morphine used for?

Bupivacaine with intrathecal morphine is indicated for Perioperative analgesia and anesthesia, Spinal anesthesia with enhanced postoperative pain control.

Who makes Bupivacaine with intrathecal morphine?

Bupivacaine with intrathecal morphine is developed and marketed by Centre Hospitalier Universitaire Vaudois (see full Centre Hospitalier Universitaire Vaudois pipeline at /company/centre-hospitalier-universitaire-vaudois).

What drug class is Bupivacaine with intrathecal morphine in?

Bupivacaine with intrathecal morphine belongs to the Local anesthetic with intrathecal opioid class. See all Local anesthetic with intrathecal opioid drugs at /class/local-anesthetic-with-intrathecal-opioid.

What development phase is Bupivacaine with intrathecal morphine in?

Bupivacaine with intrathecal morphine is FDA-approved (marketed).

What are the side effects of Bupivacaine with intrathecal morphine?

Common side effects of Bupivacaine with intrathecal morphine include Hypotension, Bradycardia, Respiratory depression, Pruritus, Nausea and vomiting, Urinary retention.

What does Bupivacaine with intrathecal morphine target?

Bupivacaine with intrathecal morphine targets Voltage-gated sodium channels (bupivacaine); mu-opioid receptors (morphine) and is a Local anesthetic with intrathecal opioid.

Related